Cyclin D1 and Cyclin E1 expressions were compared for impact on survival for gastric cancer, and it was observed that Cyclin E-negative cancers portrayed good outcomes, while Cyclin E-positive cancers showed worse outcomes, as indicated through survival curves. Here, CCND1 is linked to cancer.